PARIS, France—Treating a failed bioprosthesis via transcatheter aortic valve replacement (TAVR)—the so-called valve-in-valve approach—is feasible and often effective but technically demanding, ...

University of Iowa Health Care recently debuted a new, minimally invasive heart valve procedure after years of research and months of work toward approval by the Federal Drug Administration. A second ...